Ultragenyx Pharmaceutical Inc at Citi Global Healthcare Conference Transcript
Welcome, everyone. I'm Yigal Nochomovitz, one of the biotech analysts at Citi, and welcome to our Global Healthcare Conference in Miami. So our next session is with Ultragenyx. We have the Chief Medical Officer, Eric Crombez.
Eric, welcome. Thank you for making the trip. We've been covering you for many years and have been a lot of progress.
Questions & Answers
So maybe we could start out just at a high level. You obviously have a very important catalyst coming up essentially imminently with setrusumab. So before we get into the details of that, just kind of set the stage as far as what is the opportunity there? You had and are continuing to have a lot of success with Crysvita, another genetic disease. So talk about what the opportunity is in osteogenesis imperfecta and how you're setting up for a market launch there?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
